How to buy Integrated Research (IRI) shares

Learn how to easily invest in Integrated Research shares.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Integrated Research is a software-application business based in Australia. Integrated Research shares (IRI) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Integrated Research has a trailing 12-month revenue of around $78.5 million. If you're looking to buy shares, check out the steps below.

How to buy shares in Integrated Research

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Integrated Research . Find the share by name or ticker symbol: IRI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Integrated Research reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Integrated Research . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Integrated Research stock price (ASX:IRI)

Use our graph to track the performance of IRI stocks over time.

Integrated Research shares at a glance

Information last updated 2022-01-16.
52-week range$1.11 - $2.78
50-day moving average $1.2699
200-day moving average $1.8149
Target price$1.5
PE ratio 24.1304
Dividend yield $0.037 (3.3%)
Earnings per share (TTM) $0.046

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
ASX shares, US shares, ETFs
Earn up to 15,000 Qantas frequent flyer points when you transfer an exisiting balance or trade. Offer valid for all new and existing Superhero members until 28 February.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
GO Markets Share Trading
ASX shares, Forex, CFDs, ETFs
Pay zero brokerage on your first 20 trades and $7.70 after that on over 2,500 ASX listed shares from either your desktop or mobile.
ThinkMarkets Share Trading
AUD $8
ASX shares
$8 flat fee brokerage for CHESS Sponsored ASX stocks (HIN ownership), plus free live stock price data on an easy to use mobile app.
Saxo Capital Markets (Classic account)
AUD $5
ASX shares, Global shares, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
HSBC Online Share Trading
AUD $19.95
ASX shares, mFunds, ETFs, Bonds
Limited-time offer: Join HSBC’s online trading account before 28 February 2022 and HSBC will reimburse you up to $100 on your first 5 trades. Also traders who transfer $50k+ will get a $200 bonus(T&Cs apply).
Make trades online with brokerage fees starting from just $19.95 with an HSBC Online Share Trading account. Plus gain access to complimentary expert research, trading ideas and tools.
SelfWealth (Basic account)
AUD $9.5
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.

Compare up to 4 providers

Is it a good time to buy Integrated Research stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Integrated Research price performance over time

Historical closes compared with the last close of A$1.11

1 week (2022-01-10) -3.90%
1 month (2021-12-17) -5.93%
3 months (2021-10-15) -31.69%
6 months (2021-07-17) -37.64%
1 year (2021-01-15) -55.60%
2 years (2020-01-17) -62.12%
3 years (2019-01-17) -51.74%
5 years (2017-01-17) -59.04%

Is Integrated Research under- or over-valued?

Valuing Integrated Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integrated Research 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Integrated Research 's P/E ratio

Integrated Research 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Integrated Research shares trade at around 24x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Integrated Research 's EBITDA

Integrated Research 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.5 million (£0.0 million).

The EBITDA is a measure of a Integrated Research 's overall financial performance and is widely used to measure a its profitability.

Integrated Research financials

Revenue TTM $78.5 million
Operating margin TTM 12.46%
Gross profit TTM $78.5 million
Return on assets TTM 4.45%
Return on equity TTM 9.57%
Profit margin 10.11%
Book value 0.484
Market capitalisation $191.4 million

TTM: trailing 12 months

Integrated Research share dividends


Dividend payout ratio: 81.52% of net profits

Recently Integrated Research has paid out, on average, around 81.52% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.83% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Integrated Research shareholders could enjoy a 3.83% return on their shares, in the form of dividend payments. In Integrated Research 's case, that would currently equate to about A$0.037 per share.

Integrated Research 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 1 September 2020 (the "ex-dividend date").

Integrated Research share price volatility

Over the last 12 months, Integrated Research 's shares have ranged in value from as little as $1.11 up to $2.78. A popular way to gauge a stock's volatility is its "beta".

IRI.AU volatility(beta: 0.76)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Integrated Research 's is 0.761. This would suggest that Integrated Research 's shares are less volatile than average (for this exchange).

Integrated Research overview

Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications. It also provides testing, maintenance, and professional services, as well as software as a service solution. The company offers its products in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, as well as through channel-driven distribution networks internationally. It serves stock exchanges, banks, credit card companies, telecommunications carriers, service providers, and manufacturers. The company was incorporated in 1988 and is based in North Sydney, Australia.

Integrated Research in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site